NEW YORK, Aug. 30, 2011 /PRNewswire/ –Reportlinker.com
announces that a new market research report is available in its
catalogue:
Specialty Pharmaceutical Industry – 2011 Yearbook
http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry—2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Summary
GBI Research’s “Specialty Pharmaceutical Industry – 2011
Yearbook” essentially provides insights on specialty pharmaceutical
sales and price forecasts until 2017. The report provides in-depth
therapeutics analysis of eight niche indications, namely: Human
Immunodeficiency Virus (HIV)/Acquired immune deficiency syndrome
(AIDS), age related macular degenerative disorders, attention
deficit hyperactivity disorder (ADHD), Alzheimer’s disease,
colorectal cancer, rheumatoid arthritis, epilepsy and glaucoma,
including their annual cost of therapy (ACT) and revenue. In
addition, the geographical distribution of these disorders
therapies across the US, the top five countries in the European
region and Japan are also provided in the report. The report also
includes insights into the specialty pharmaceutical Research and
Development (R&D) pipeline and the potential future
blockbusters up to 2017. Furthermore, it also covers the market
forecasts and treatment usage patterns of these eight therapeutic
indications up to 2017. Finally, the key trend analysis on Mergers
and Acquisitions (M&A), licensing agreements and co-development
deals involving specialty pharmaceuticals is also presented.
Scope
The report covers –
– Annualized market data for the specialty pharmaceutical market
from 2001 t
‘/>”/>
SOURCE
